Syngene International
-
Franchise India Bureau May 31 2018 - 1 min readSyngene International, a research company, and Zumutor Biologics, an emerging immuno-oncology company, have entered into a non-exclusive partnering agreement to access Zumutor's proprietary naïve human phage/yeast display library. This collaboration further enhances Syngene's market-leading capabilities in discovery biology, providing its scientists with additional tools to help solve complex biology problems in ...
-
PTI Sep 29 2017 - 1 min readMauritius-based private equity fund Silver Leaf Oak will acquire 10 per cent stake in Biocon's research services arm Syngene International for Rs 380 crore, as per a PTI report. The deal puts the entire valuation of Syngene International Ltd, a wholly-owned subsidiary of Biocon Ltd, at Rs 3,800 crore.